Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting

NCT07692451 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Nausea and Vomiting Induced by Antibody-drug Conjugates (ADCs)

Interventions

DRUG: Fosrolapitant and Palonosetron for injection

Sponsor

Peking University Cancer Hospital & Institute